Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Inflammation01:38

Inflammation

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Very strong correlations of metoprolol- and solanidine-derived metabolic ratios in a real-world cohort with a stable metoprolol drug regimen.

Frontiers in pharmacology·2026
Same author

Lipoprotein(a) and residual cardiovascular risk in statin-treated patients.

European journal of preventive cardiology·2026
Same author

Diabetes Mellitus and the Heart.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2026
Same author

Prediction or speculation: heart failure models for diabetes.

European journal of heart failure·2026
Same author

CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum.

Cardiovascular diabetology·2026
Same author

Therapy of Type 2 Diabetes.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2026

Related Experiment Video

Updated: Jul 9, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

[LDL cholesterol--why lower and lower?].

Dirk Müller-Wieland1, J Kotzka

  • 1I. Medizinischen Abt. Asklepios Klinik St. Georg, Hamburg. dirk.mueller-wieland@ak-stgeorg.lbk-hh.de

MMW Fortschritte Der Medizin
|December 12, 2007
PubMed
Summary
This summary is machine-generated.

Lowering LDL cholesterol with statins significantly reduces cardiovascular risk. Achieving lower LDL cholesterol levels (< 70 mg/dl) can halt or even reverse plaque growth in high-risk patients.

Related Experiment Videos

Last Updated: Jul 9, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Area of Science:

  • Cardiology
  • Pharmacology
  • Preventive Medicine

Context:

  • Large interventional studies demonstrate the efficacy of statin therapy.
  • Cardiovascular disease remains a leading cause of mortality worldwide.
  • Risk stratification is crucial for managing high-risk patient populations.

Purpose:

  • To summarize the established benefits of LDL cholesterol lowering on cardiovascular risk.
  • To highlight target LDL cholesterol levels for high-risk individuals.
  • To present emerging evidence on the impact of very low LDL cholesterol on atherosclerotic plaques.

Summary:

  • Statin-induced reduction of low-density lipoprotein (LDL) cholesterol by 25-30% is linked to substantial cardiovascular risk reduction.
  • For high-risk patients, target plasma LDL cholesterol levels should be below 100 mg/dl, with a goal of 30-40% reduction if initially lower.
  • Recent research indicates that achieving LDL cholesterol levels below 70 mg/dl may inhibit atherosclerotic plaque progression and potentially induce regression.

Impact:

  • Provides evidence-based targets for lipid management in cardiovascular disease prevention.
  • Reinforces the importance of aggressive LDL cholesterol lowering in high-risk individuals.
  • Suggests a paradigm shift towards more intensive lipid-lowering strategies for plaque stabilization and regression.